Dr. Cybele Ghossein, MD

Dr. Ghossein practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Ghossein's NPI, 1376588830, was assigned on June 18, 2006. Dr. Ghossein graduated from Albert Einstein College of Medicine in 1990. Dr. Ghossein holds Illinois license 036098265.

Dr. Ghossein's primary practice is Northwestern Medical Group, at 675 N Saint Clair St Ste 19-100 Suite 19-100, Chicago, IL 60611. The practice phone is (312) 664-3278.

Dr. Ghossein's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Ghossein is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Ghossein to 2 more hospitals and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghossein practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ghossein's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Ghossein is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ghossein's licenses on file in 2 states: Illinois and Pennsylvania.

Dmand AI lists chronic anemia, chronic kidney disease, hypercalcemia and kidney disease among the conditions Dr. Ghossein treats.

CMS data shows 394 Medicare services from Dr. Ghossein across 5 procedure codes in 2024, for 194 Medicare patients. Medicare paid $35,501 for them.

CMS counts 194 Medicare patients who saw Dr. Ghossein in 2024. The largest group is 75 to 84, with 70 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghossein's median patient age at 65, with 52% women.

In 2024, Dr. Ghossein wrote 718 Medicare Part D claims for 113 patients. 87% of them were for generic drugs. CMS names the drug for 511 of them, across 18 drugs with 11 or more claims each, at $60,190 in total drug cost. In 2023, CMS named 559 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Ghossein for performance year 2024, reported through an alternative payment model (APM). Dr. Ghossein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghossein as offering telehealth.

Dmand AI links 31 papers to Dr. Ghossein, published from 2010 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Acute Kidney Injury, Kidney Failure, Chronic and Renal Dialysis. Dr. Ghossein has published most often in Am J Kidney Dis. Dr. Ghossein's most frequent co-authors are Craig Bradford Langman, MD, Grant D. Barish, MD and Kerri Lyn Cavanaugh, MD.

Dmand AI links Dr. Ghossein to 1 clinical trial. Conditions studied include Renal Insufficiency and Kidney Diseases.

CMS Open Payments shows 30 general payments to Dr. Ghossein from 5 drug and device companies from 2019 to 2025. Honoraria make up the largest share, 67% of the total. Horizon Pharma plc paid the most, $16,629.

Dmand AI lists 3 awards for Dr. Ghossein, most recently CMS Stage 1 2012 in 2011.

Dr. Ghossein graduated from Albert Einstein College of Medicine in 1990.

Dr. Ghossein is in network with 15 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.